CATHERINE BENNETT: Open Payments
NPI 1427504042 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,099 in 41 payments from 15 companies in 2025. Trend: 2023 $2,985 · 2024 $2,555 · 2025 $1,099
Food & beverage: $1,099
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $238 |
| Regeneron Healthcare Solutions, Inc. | 4 | $174 |
| GENZYME CORPORATION | 3 | $107 |
| Inspire Medical Systems, Inc. | 1 | $104 |
| Axsome Therapeutics, Inc. | 6 | $89 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $83 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| Shionogi Inc | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| JAZZ PHARMACEUTICALS INC. | 2 | $35 |
Products named: DUPIXENT, BREZTRI, INSPIRE, Sunosi, LUMRYZ, Fetroja, AIRSUPRA, TRELEGY ELLIPTA.
Industry payments across IL — which companies pay providers there.
